HEIP
PFE icon

Hudson Edge Investment Partners’s Pfizer PFE Stock Holding History

Hudson Edge Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,748
Closed -$285K – 171
2024
Q4 		$285K Hold
10,748
– – 0.05% 117
2024
Q3 		$311K Sell
10,748
-400
-4% -$11.7K 0.06% 129
2024
Q2 		$312K Hold
11,148
– – 0.06% 126
2024
Q1 		$309K Sell
11,148
-250
-2% -$6.94K 0.06% 136
2023
Q4 		$328K Buy
11,398
+300
+3% +$9.07K 0.08% 125
2023
Q3 		$368K Buy
+11,098
New +$392K 0.12% 107
2023
Q2 		– Sell
-11,098
Closed -$453K – 133
2023
Q1 		$453K Sell
11,098
-600
-5% -$25.9K 0.14% 108
2022
Q4 		$599K Sell
11,698
-50
-0.4% -$2.4K 0.2% 83
2022
Q3 		$514K Hold
11,748
– – 0.19% 96
2022
Q2 		$616K Sell
11,748
-2
-0% -$102 0.22% 79
2022
Q1 		$608K Hold
11,750
– – 0.19% 103
2021
Q4 		$694K Sell
11,750
-160
-1% -$7.93K 0.22% 85
2021
Q3 		$512K Hold
11,910
– – 0.17% 120
2021
Q2 		$466K Sell
11,910
-40
-0.3% -$1.56K 0.15% 122
2021
Q1 		$433K Sell
11,950
-50
-0.4% -$1.77K 0.14% 115
2020
Q4 		$442K Sell
12,000
-648
-5% -$23.8K 0.16% 116
2020
Q3 		$440K Hold
12,648
– – 0.18% 114
2020
Q2 		$392K Buy
12,648
+316
+3% +$10.7K 0.13% 106
2020
Q1 		$382K Hold
12,332
– – 0.15% 93
2019
Q4 		$458K Hold
12,332
– – 0.12% 123
2019
Q3 		$420K Sell
12,332
-2,951
-19% -$107K 0.12% 118
2019
Q2 		$628K Hold
15,283
– – 0.18% 66
2019
Q1 		$616K Sell
15,283
-1
-0% -$40 0.19% 57
2018
Q4 		$633K Sell
15,284
-52
-0.3% -$2.16K 0.2% 65
2018
Q3 		$641K Sell
15,336
-274,405
-95% -$10.6M 0.11% 83
2018
Q2 		$9.97M Sell
289,741
-133,764
-32% -$4.57M 1.86% 23
2018
Q1 		$14.3M Sell
423,505
-9,079
-2% -$312K 2.16% 9
2017
Q4 		$14.9M Sell
432,584
-12,769
-3% -$435K 2.05% 13
2017
Q3 		$15.1M Buy
445,353
+159,277
+56% +$5.12M 2.14% 9
2017
Q2 		$9.12M Sell
286,076
-17,285
-6% -$545K 1.28% 45
2017
Q1 		$9.85M Buy
303,361
+1,697
+0.6% +$53.5K 1.31% 42
2016
Q4 		$9.3M Buy
301,664
+2,808
+0.9% +$85.7K 1.27% 42
2016
Q3 		$9.6M Sell
298,856
-38,540
-11% -$1.29M 1.44% 45
2016
Q2 		$11.3M Sell
337,396
-103,181
-23% -$3.29M 1.68% 38
2016
Q1 		$12.4M Buy
440,577
+172,608
+64% +$4.93M 1.23% 39
2015
Q4 		$8.21M Buy
267,969
+250,051
+1,396% +$7.87M 0.79% 46
2015
Q3 		$534K Buy
17,918
+1,054
+6% +$33.8K 0.03% 110
2015
Q2 		$536K Sell
16,864
-1,581
-9% -$51.5K 0.02% 115
2015
Q1 		$609K Sell
18,445
-53
-0.3% -$1.69K 0.03% 113
2014
Q4 		$547K Sell
18,498
-1
-0% -$29 0.02% 117
2014
Q3 		$519K Hold
18,499
– – 0.02% 118
2014
Q2 		$521K Buy
18,499
+1,054
+6% +$30K 0.02% 111
2014
Q1 		$532K Hold
17,445
– – 0.02% 107
2013
Q4 		$507K Sell
17,445
-3,446
-16% -$100K 0.02% 110
2013
Q3 		$569K Sell
20,891
-1,623
-7% -$44.2K 0.02% 106
2013
Q2 		$598K Buy
+22,514
New +$622K 0.02% 106

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hudson Edge Investment Partners's PFE Position: Q1 2025 in Review

Hudson Edge Investment Partners sold out of Pfizer (PFE) in Q1 2025, closing a stake of 10,748 shares — an estimated $285K sold.

Hudson Edge Investment Partners first reported a position in PFE in Q2 2013 and held it in 46 quarters. The position peaked at $15.1M in Q3 2017. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Hudson Edge Investment Partners reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Hudson Edge Investment Partners sold 10,748 Pfizer shares in Q1 2025, an estimated $285K.
  • Hudson Edge Investment Partners first reported a position in Pfizer in Q2 2013 and held it in 46 quarters.
  • Hudson Edge Investment Partners's Pfizer position peaked at $15.1M in Q3 2017.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Hudson Edge Investment Partners's 13F filing for Q1 2025, filed 28 Apr 2025.